國立高雄大學圖資館 |

Language: English

Back

Organotypic models in drug development

Landsiedel, Robert.

Organotypic models in drug development

Record Type:	Electronic resources : Monograph/item
Title/Author:	Organotypic models in drug developmentedited by Monika Schafer-Korting, Silvya Stuchi Maria-Engler, Robert Landsiedel.
other author:	Schafer-Korting, Monika.
Published:	Cham :Springer International Publishing :2021.
Description:	viii, 323 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Drug development.
Online resource:	https://doi.org/10.1007/978-3-030-70063-8
ISBN:	9783030700638$q(electronic bk.)

Organotypic models in drug development
Organotypic models in drug development[electronic resource] /edited by Monika Schafer-Korting, Silvya Stuchi Maria-Engler, Robert Landsiedel. - Cham :Springer International Publishing :2021. - viii, 323 p. :ill. (some col.), digital ;24 cm. - Handbook of experimental pharmacology,v.2650171-2004 ;. - Handbook of experimental pharmacology ;208..

Inflammatory skin disease models in vitro and in animals - predictability for drug development -- Neural In Vitro Models for Studying Substances Acting on the Central Nervous System -- Quality of commercial tissues Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future Development -- Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh -- Disease Models: Lung models for testing drugs against inflammation and infection -- In Vitro Models of the Blood-Brain Barrier -- How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development -- The CAM Assay as an Alternative In Vivo Model for Drug Testing -- Organotypic Models in Drug Development "Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development -- Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling -- Immunocompetent human intestinal models in preclinical drug development -- Engineered Heart Muscle Models in Phenotypic Drug Screens.

This book provides latest findings in organotypic models in drug development and provides the scientific resonance needed in an emerging field of research in disciplines, such as molecular medicine, physiology, and pathophysiology. Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.

ISBN: 9783030700638$q(electronic bk.)

Standard No.: 10.1007/978-3-030-70063-8doiSubjects--Topical Terms:

190608
Drug development.

LC Class. No.: RM301.25

Dewey Class. No.: 615.19

Organotypic models in drug development
LDR:02648nmm a2200337 a 4500 001 599148
003 DE-He213
005 20210621142846.0
006 m d
007 cr nn 008maaau
008 211027s2021 sz s 0 eng d
020 $a 9783030700638$q(electronic bk.)
020 $a 9783030700621$q(paper)
024 7 $a 10.1007/978-3-030-70063-8 $2 doi
035 $a 978-3-030-70063-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .O68 2021
245 0 0 $a Organotypic models in drug development $h [electronic resource] / $c edited by Monika Schafer-Korting, Silvya Stuchi Maria-Engler, Robert Landsiedel.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a viii, 323 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.265
505 0 $a Inflammatory skin disease models in vitro and in animals - predictability for drug development -- Neural In Vitro Models for Studying Substances Acting on the Central Nervous System -- Quality of commercial tissues Standardised Reconstructed Skin Models in Toxicology and Pharmacology: State of the Art and Future Development -- Human-Derived In Vitro Models Used for Skin Toxicity Testing Under REACh -- Disease Models: Lung models for testing drugs against inflammation and infection -- In Vitro Models of the Blood-Brain Barrier -- How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development -- The CAM Assay as an Alternative In Vivo Model for Drug Testing -- Organotypic Models in Drug Development "Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development -- Tissue Engineering for Musculoskeletal Regeneration and Disease Modeling -- Immunocompetent human intestinal models in preclinical drug development -- Engineered Heart Muscle Models in Phenotypic Drug Screens.
520 $a This book provides latest findings in organotypic models in drug development and provides the scientific resonance needed in an emerging field of research in disciplines, such as molecular medicine, physiology, and pathophysiology. Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years. Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.
650 0 $a Drug development. $3 190608
650 0 $a Tissue engineering. $3 239499
650 0 $a Tissue culture. $3 188548
650 0 $a Pharmacology, Experimental. $3 274313
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Gene Therapy. $3 196467
650 2 4 $a Pathology. $3 196513
700 1 $a Schafer-Korting, Monika. $3 594641
700 1 $a Stuchi Maria-Engler, Silvya. $3 893236
700 1 $a Landsiedel, Robert. $3 850797
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u https://doi.org/10.1007/978-3-030-70063-8
950 $a Biomedical and Life Sciences (SpringerNature-11642)